RNS Number : 7903W
SDI Group PLC
19 April 2023
 

 

SDI Group plc

 

("SDI", "SDI Group", the "Company", or the "Group")

 

Exercise of Share Options, Director/PDMR Shareholding and Total Voting Rights

SDI Group plc, the AIM quoted group focused on the design and manufacture of scientific and technology products for use in digital imaging and sensing and control applications, announces that it has issued and allotted a total of 272,868 new ordinary shares of 1 penny each in the capital of the Company ("Ordinary Shares") following an exercise of a number of options.

SDI has been notified that Mike Creedon, Chief Executive Officer, has exercised 178,872 of approved share options at a price of 24.5 pence. Following the exercise and Admission, Mike Creedon will hold 351,372 shares, representing 0.34% of the ordinary shares held. A further 93,996 share options have been exercised by a former employee of the Group. 

Application has been made to the London Stock Exchange for the 272,868 new Ordinary Shares to be admitted to trading on AIM ("Admission") and it is expected that Admission will become effective and trading will commence at 8.00 a.m. on or around 26 April 2023.

 

Following Admission, the total number of Ordinary Shares in issue will be 104,050,044 and the total number of voting rights will therefore be 104,050,044. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

Enquiries

 

SDI Group plc 

Ken Ford, Chairman                                                                                01223 727144

Ami Sharma, CFO

www.sdigroup.com

 

finnCap Ltd                                                                                                       020 7220 0500

Ed Frisby/Seamus Fricker - Corporate Finance

Andrew Burdis/Sunila de Silva - ECM

 

 

About SDI Group plc:

 

SDI designs and manufactures scientific and technology products for use in digital imaging and sensing and control applications including life sciences, healthcare, astronomy, plastics and packaging, manufacturing, precision optics, measurement instrumentation and art conservation. SDI operates through its subsidiaries: Atik Cameras, Synoptics, Graticules Optics, Sentek, Astles Control Systems, Applied Thermal Control, MPB Industries, Chell Instruments, Monmouth Scientific, Uniform Engineering, Scientific Vacuum Systems, Safelab Systems, LTE Scientific and Fraser Anti-Static Techniques.

SDI continues to grow by developing its own technology advancements and by improving its global sales channels, as well as through pursuing strategic, complementary acquisitions.

1.           

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Mike Creedon

2.           

Reason for the Notification

a)

Position/status

Chief Executive Officer

b)

Initial notification/Amendment

Initial Notification

3.  

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

SDI Group plc

b)

LEI

213800YA3XW7JRE46Z70

4.  

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary shares of 1p each ("Ordinary Shares")

Identification code

GB00B3FBWW43

b)

Nature of the transaction

Exercise of options

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

Exercise of options

24.5 pence

178,872

 

d)

Aggregated information:

·Aggregated volume

·Price

 

Exercise of 178,872 options at a price of 24.5 pence per Ordinary Share

e)

Date of the transaction

19 April 2023

f)

Place of the transaction

Outside a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHZZGMDMLNGFZM